{"id":492169,"date":"2010-03-31T03:40:27","date_gmt":"2010-03-31T07:40:27","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=70982"},"modified":"2010-03-31T03:40:27","modified_gmt":"2010-03-31T07:40:27","slug":"introducing-under-the-radar-funding-in-san-diego-four-startup-financings-you-probably-haven%e2%80%99t-heard-about","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/492169","title":{"rendered":"Introducing Under-the-Radar Funding in San Diego: Four Startup Financings You Probably Haven\u2019t Heard About"},"content":{"rendered":"\n
startups<\/a>, funding<\/a>, deals<\/a><\/div>\n

\t\tErin Kutz wrote:<\/strong><\/p>\n

Since June we’ve been tracking monthly figures in bigger venture deals for our two other coverage areas, Seattle and Boston, thanks to data provided to us by our New York-based partner CB Insights<\/a>, a private company intelligence platform. The company also supplies us monthly with a list of smaller deals under $1 million—what we dub as “under the radar”—in Southern California, the Northwest, and New England, which we like to examine for trends in startup investing.<\/p>\n

This was the first month that enough San Diego-area companies made the list to merit a story, which could signal that pint-sized deals are picking up for the region’s startups. There were four San Diego deals, ranging from $201,132 to $689,500. Three were equity-based offerings, and a fourth was debt-related. While these four deals were all relatively small, they definitely signal bigger things to come, as three of the four transactions reflected pieces of larger planned offerings.<\/p>\n

The startups that nabbed the funding cover the energy, medical devices, pharmaceutical, and agriculture spaces. That’s right, agriculture. Yes, it’s not typically an industry that we’d cover, but I kept the $201,132 in equity, options, and warrants for San Diego-based Cibus Global<\/a> on the list because of the way the company has been innovating in the area of crop trait development.<\/p>\n

Rather than using traditional genetic engineering technologies of introducing foreign traits to crops, Cibus works within plants’ own genomes to introduce genetic traits through the natural process of gene repair<\/a>. I’m interested to see where they go, particular because their February deal was just a piece of a planned $2.6 million offering, according to the SEC filing.<\/p>\n

The biggest deal on the list was $689,500 of a planned $1 million equity offering for Carlsbad, CA-based Catadon Systems. They’re engineering towers<\/a> that raise wind turbines higher into the air without the need for cranes or concrete, according to the company’s website. The higher a turbine can be placed off the ground, the more wind energy it can capture, making wind investments pay off faster, the website explains.<\/p>\n

The sole debt deal went to San Diego-based Aethlon Medical<\/a>, in a $600,000 transaction that included options and warrants. Aethlon is developing a diagnostic and therapeutic device for infectious diseases. Their Hemopurifier is a cartridge that removes viral pathogens from the blood and can be used with portable pumps or dialysis machines.<\/p>\n

If you ask me, these under-the-radar lists can be nicknamed the stealth lists, due to the fact that they almost always include at least one company that’s too stealthy to have a website. La Jolla’s Ampla Pharmaceuticals took on that role for the February list. The only information I could gather on them was from the website of their investor, Integra Ventures<\/a> of Seattle. Integra’s website describes Ampla as a “stealth mode biotechnology company,” and says that Advent International and Crabtree Ventures also back the company. Ampla pulled in $295,271 of a planned $1.2 million equity-based offering.<\/p>\n

I’m interested to see when these companies will complete their offerings, or roar out of stealth mode. In the meantime, check out the consolidated list below of February under-the-radar deals.<\/p>\n\n\n\n\n\n\n
Catadon Systems<\/a><\/td>\nCarlsbad,\u00a0\u00a0 CA<\/td>\nA maker of towers for elevating wind turbines<\/td>\nEquity<\/td>\n$689,500<\/td>\n<\/tr>\n
Aethlon Medical<\/a><\/td>\nSan Diego, CA<\/td>\nA developer of a medical device to treat infectious diseases<\/td>\nDebt*<\/td>\n$600,000<\/td>\n<\/tr>\n
Ampla Pharmaceuticals<\/a><\/td>\nLa Jolla,\u00a0\u00a0\u00a0\u00a0 CA<\/td>\nA stealthy biotech company<\/td>\nEquity<\/td>\n$295,271<\/td>\n<\/tr>\n
Cibus Global <\/a><\/td>\nSan Diego, CA<\/td>\nA developer of environmentally friendly technology for producing crop traits<\/td>\nEquity*<\/td>\n$201,132<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*includes some options and warrants<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

\t \t\t

\n

\n\"\"<\/a>
\n<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

startups, funding, deals Erin Kutz wrote: Since June we’ve been tracking monthly figures in bigger venture deals for our two other coverage areas, Seattle and Boston, thanks to data provided to us by our New York-based partner CB Insights, a private company intelligence platform. The company also supplies us monthly with a list of smaller […]<\/p>\n","protected":false},"author":1661,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15,7],"tags":[],"class_list":["post-492169","post","type-post","status-publish","format-standard","hentry","category-energy","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/492169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1661"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=492169"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/492169\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=492169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=492169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=492169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}